R Squared Ltd Takes $272,000 Position in OrthoPediatrics Corp. $KIDS

R Squared Ltd purchased a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 12,682 shares of the company’s stock, valued at approximately $272,000.

Other institutional investors also recently modified their holdings of the company. Goldman Sachs Group Inc. raised its position in shares of OrthoPediatrics by 112.3% in the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Harbor Capital Advisors Inc. raised its position in shares of OrthoPediatrics by 116.5% in the second quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company’s stock valued at $7,173,000 after purchasing an additional 179,733 shares during the period. Invesco Ltd. raised its position in shares of OrthoPediatrics by 12.1% in the first quarter. Invesco Ltd. now owns 18,349 shares of the company’s stock valued at $452,000 after purchasing an additional 1,986 shares during the period. Triodos Investment Management BV raised its position in shares of OrthoPediatrics by 25.0% in the second quarter. Triodos Investment Management BV now owns 112,500 shares of the company’s stock valued at $2,415,000 after purchasing an additional 22,500 shares during the period. Finally, American Century Companies Inc. raised its position in shares of OrthoPediatrics by 16.1% in the first quarter. American Century Companies Inc. now owns 30,658 shares of the company’s stock valued at $755,000 after purchasing an additional 4,248 shares during the period. Institutional investors own 69.05% of the company’s stock.

Insiders Place Their Bets

In other OrthoPediatrics news, CFO Fred Hite purchased 5,076 shares of the firm’s stock in a transaction on Thursday, August 21st. The shares were purchased at an average price of $19.41 per share, for a total transaction of $98,525.16. Following the completion of the purchase, the chief financial officer directly owned 213,065 shares of the company’s stock, valued at approximately $4,135,591.65. This represents a 2.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 32.70% of the stock is owned by corporate insiders.

OrthoPediatrics Stock Down 0.2%

KIDS opened at $17.03 on Friday. OrthoPediatrics Corp. has a fifty-two week low of $15.28 and a fifty-two week high of $32.00. The company has a debt-to-equity ratio of 0.27, a current ratio of 6.66 and a quick ratio of 3.43. The firm’s fifty day moving average price is $19.13 and its two-hundred day moving average price is $20.59. The company has a market capitalization of $426.94 million, a P/E ratio of -9.51 and a beta of 1.02.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Monday, January 9th. The company reported ($0.15) earnings per share for the quarter. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The business had revenue of $25.08 million for the quarter. On average, analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Wall Street Analysts Forecast Growth

KIDS has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on shares of OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. BTIG Research lowered their price objective on shares of OrthoPediatrics from $39.00 to $23.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Lake Street Capital lowered their price objective on shares of OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Wall Street Zen downgraded shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research note on Saturday, October 11th. Finally, JMP Securities lowered their price objective on shares of OrthoPediatrics from $35.00 to $25.00 and set a “market outperform” rating on the stock in a research note on Friday, October 10th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, OrthoPediatrics currently has an average rating of “Moderate Buy” and a consensus target price of $26.29.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.